Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
NCT01525719 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-02-03
Summary
The purpose of this study is to determine whether everolimus is effective in the treatment of patients with advance cholangiocarcinoma.
Conditions
Interventions
- DRUG
-
10 mg everolimus
Sponsors & Collaborators
-
Ratchavithi Hospital
lead OTHER_GOV
Principal Investigators
-
Kawin Leelawat, MD, PhD · Department of Medical Services Ministry of Public Health of Thailand
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-06-30
More Related Trials
-
Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction
NCT01042782 ·Status: COMPLETED ·Phase: PHASE1
-
Gastric Cancer RAD001 Study
NCT01514110 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
NCT01099527 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2
NCT05403242 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
NCT00917384 ·Status: COMPLETED ·Phase: PHASE3
-
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
NCT04803318 ·Status: RECRUITING ·Phase: PHASE2
-
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach
NCT01640782 ·Status: COMPLETED ·Phase: PHASE3
-
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
NCT07309185 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
NCT06607276 ·Status: RECRUITING ·Phase: PHASE2
-
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy
NCT01248403 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
NCT00544193 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT05948449 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer
NCT06475417 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer
NCT06437678 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
NCT01053390 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT06956716 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
NCT07311408 ·Status: RECRUITING ·Phase: PHASE2
-
Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
NCT06247956 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma
NCT05563012 ·Status: RECRUITING ·Phase: PHASE2
-
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
NCT01049620 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00400179 ·Status: COMPLETED ·Phase: PHASE3
-
Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors
NCT05291052 ·Status: UNKNOWN ·Phase: PHASE2
-
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
NCT05715632 ·Status: UNKNOWN ·Phase: NA
-
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
NCT06492317 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study
NCT07266025 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2